4 нояб. 2024 г. · EU antitrust regulators will decide by Dec. 6 whether to clear Novo Holdings' acquisition of contract drug manufacturer Catalent (CTLT.N).

22 нояб. 2024 г. · Novo Holdings is set to gain unconditional EU antitrust approval for its planned $16.5 billion takeover of U.S. contract drug maker Catalent ...

7 дней назад · While it's not perfect, its approach to merger challenges is supposed to be based on antitrust analysis rather than changing political ...

30 окт. 2024 г. · Novo's plans encountered antitrust concerns from lawmakers, consumer ... Novo and Catalent may need to make concessions before carrying through ...

8 нояб. 2024 г. · Novo Holdings' $16.5 billion acquisition of CDMO giant Catalent continues to be under antitrust scrutiny by global regulators.

5 нояб. 2024 г. · Antitrust & Cartels · Latest news Cartels cases and statistics Contact ... NOVO HOLDINGS / NOVO NORDISK / CATALENT. Companies: NOVO ...

18 окт. 2024 г. · Novo Holdings is encountering more resistance as it aims to close its $16.5 billion acquisition of pharma manufacturing giant Catalent by the end of the year.

4 нояб. 2024 г. · European Union regulators are expected to deliver a decision by December 6 on whether to approve Novo Holdings' acquisition of Catalent.

4 нояб. 2024 г. · EU antitrust regulators will decide by Dec. 6 whether to clear Novo Holdings' acquisition of contract drug manufacturer Catalent.

21 окт. 2024 г. · Catalent's acquisition by Novo Holdings is expected to close towards the end of calendar year 2024, subject to customary closing conditions.